Biotech
Genentech
Genentech raises $60B Public at $65B valuation
1 DNA Way, South San Francisco, CA 94080January 1, 20241 min read
Latest funding
$60B
Valuation
$65B
Latest Round
Public
Employees
16000+
Genentech: Public Funding Round
Genentech has successfully raised $60B in Public funding, reaching a valuation of $65B.
Company Overview
Biotechnology company
Funding Details
The Public round was led by Roche.
Company Information
- Headquarters: 1 DNA Way, South San Francisco, CA 94080
- Founded: 1976
- Employees: 16000+
- Category: Biotech
Investment
Genentech plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Roche: Verified investor in Public
Company Info
Headquarters
1 DNA Way, South San Francisco, CA 94080
Founded
1976
Team Size
16000+
Last Round
$60B(Jan 2024)
Investors (1)
R
RocheLeadLead Investor
Verified investor in Public
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started